| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.71B | $1.51B | $1.37B |
| YoY Revenue Growth % | +13.3% | +10.5% | — |
| Gross Profit | $642.1M | $551.3M | — |
| Gross Margin % | 37.6% | 36.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $317.4M | $284.0M | $235.7M |
| Operating Margin % | 18.6% | 18.8% | 17.3% |
| Net Income (GAAP) | $98.5M | $98.3M | $88.2M |
| EBITDA (Normalized) | $360.3M | $318.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $211.7M | $145.5M | $208.7M |
| Capital Expenditures (CapEx) | $53.7M | $43.5M | — |
| Free Cash Flow (FCF) | $158.0M | $102.0M | $208.7M |
| FCF Margin % | 9.2% | 6.8% | 15.3% |
| Return on Invested Capital (ROIC %) | 93.2% | 95.0% | — |
| Cash & Short-Term Equivalents | $123.1M | $154.7M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $392.1M | -$277.3M | — |